Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS)

Overview of attention for article published in Neurology: Clinical Practice, August 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

news: 1 news outlet

Readers on

mendeley: 31 Mendeley

So far, Altmetric has seen 1 news story.

Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS): Protocol and Study Design.

Alzforum, 10 Sep 2021

Berry J, Brooks B, Genge A, Heiman-Patterson T, Appel S, Benatar M, Bowser R, Cudkowicz M, Gooch C, Shefner J, Westra J, Agnese…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.